Informações:
Falhas:
ID
12805
Descrição
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL); ODM derived from: https://clinicaltrials.gov/show/NCT01506453
Link
https://clinicaltrials.gov/show/NCT01506453
Palavras-chave
Versões (1)
- 21/12/15 21/12/15 -
Transferido a
21 de diciembre de 2015
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Acute Lymphoblastic Leukemia NCT01506453
Eligibility Acute Lymphoblastic Leukemia NCT01506453
- StudyEvent: Eligibility
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT01506453
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
total xvi protocol
Item
participant is enrolled on total xvi
boolean
C0949634 (UMLS CUI [1])
age
Item
participant is 1 year of age or older
boolean
C0001779 (UMLS CUI [1])
neuropathic pain
Item
participant has symptoms of np/pn with onset no more than 7 days after one of the following vincristine doses: protocol week 1, week 2 (induction), week 7 (reinduction i), or week 17 (reinduction ii).
boolean
C0458960 (UMLS CUI [1])
treatment protocol
Item
patient is expected to receive 2 doses of vincristine in weekly intervals as outlined by the total xvi protocol while on study drug (i.e. no known dosage reductions or planned missed doses).
boolean
C0949634 (UMLS CUI [1])
compliance
Item
participant is able and willing to take oral medications.
boolean
C1321605 (UMLS CUI [1])
study subject participation status
Item
previous participation in this study
boolean
C2348568 (UMLS CUI [1])
participant is receiving gabapentin for another indication
Item
participant is receiving gabapentin for another indication at the time of diagnosis of np/pn or has received gabapentin previously.
boolean
C0060926 (UMLS CUI [1])
C0087111 (UMLS CUI [2])
C0087111 (UMLS CUI [2])
pregnancy test negative , Contraception
Item
pregnancy. female participants of childbearing potential must have documented negative urine or serum pregnancy test result not older than 7 days. male patients with reproductive potential will be counseled not to procreate during the study.
boolean
C0427780 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
impaired renal function
Item
impaired renal function: decreased egfr (<60ml/min/1.73m^2 as estimated by the revised schwartz equation)
boolean
C0151746 (UMLS CUI [1])
participant has allergy or other contraindication for either morphine or gabapentin therapy
Item
participant has allergy or other contraindication for either morphine or gabapentin therapy.
boolean
C0020517 (UMLS CUI [1])
C0026549 (UMLS CUI [2])
C0060926 (UMLS CUI [3])
C0026549 (UMLS CUI [2])
C0060926 (UMLS CUI [3])
informed consent
Item
inability or unwillingness of research participant or legal guardian/representative to give written informed consent.
boolean
C0021430 (UMLS CUI [1])